In patent litigation between branded and generic manufacturers of canine flea & tick products, CRA was asked to assess irreparable harm. CRA examined effects from the entry and ongoing sales of the generic products, business losses suffered by the branded manufacturer and whether they could be attributed to the sale of the generic products, the influence of new channels, such as the internet, and the impact of newer, more effective classes of parasiticides. CRA submitted a declaration on irreparable harm.
CRA recognized in Lexology Index: IP
We are delighted to share that Alisa Knapp, Chris Bakewell, Dan McGavock, Dave Duski, Erin Crockett, Greg Bell, Jim Donohue, Julia Rowe, Kim Schenk, Mike Tate,...